Frazier Life Sciences has gathered an impressive $1.3 billion in capital commitments for its 12th venture fund aimed at private early-stage biotechs. The Palo Alto-based firm said it has now raised ...
With around 10,000 diseases known to humankind and over 90% that still have no approved treatments, there’s considerable demand in the specialized life science sector. As Joel Marcus, co-founder and ...
PALO ALTO, Calif.--(BUSINESS WIRE)--Frazier Life Sciences (FLS), a longstanding investment firm focused on innovative therapeutics, today announced the closing of Frazier Life Sciences XII, L.P. (FLS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results